Crohn's Disease

DENVER — Depression was associated with higher social vulnerability in individuals with inflammatory bowel disease and was largely influenced by socioeconomic and minority status, according to data at the Crohn’s and Colitis Congress.

DENVER — In a Healio video exclusive, Alan Moss, MD, discusses his presentation at the Crohn’s and Colitis Congress, which detailed the use of therapeutic drug monitoring in the management of patients with inflammatory bowel disease.

DENVER — Providers should consider de-escalating combination therapy with immunomodulators to monotherapy after 1 year in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress.

DENVER — In a Healio video exclusive, James D. Lewis, MD, MSCE, a gastroenterologist at the University of Pennsylvania Perelman School of Medicine, discusses what it might take to eventually cure or prevent inflammatory bowel disease.

DENVER — A risk stratification assessment assisted both patients with Crohn’s disease and their physicians when making decisions about treatment, according to data presented at the Crohn’s and Colitis Congress.

DENVER — Hyperbaric oxygen therapy yielded a clinical response rate of 87% among patients with fistulizing Crohn’s disease with few adverse events, according to systematic review data presented at the Crohn’s and Colitis Congress.

DENVER — Health care providers should apply cultural competency, sensitivity and humility when making dietary recommendations for patients with inflammatory bowel disease, noted a presenter at the Crohn’s and Colitis Congress.

DENVER — In a Healio video exclusive, Stefan D. Holubar, MD, MS, discusses the decades-long controversy surrounding preoperative use of biologics and risk for postoperative complications in patients with inflammatory bowel disease.

DENVER — Nutrition therapy for patients with Crohn’s disease should focus on increased and varied consumption rather than restrictive diets, according to a presenter at the Crohn’s and Colitis Congress.

DENVER — Wearable technology, including wrist-worn smartwatches that monitor heart rate variability, may help identify and predict flares of inflammatory bowel disease, according to data presented at the Crohn’s and Colitis Congress.